Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
26.74
+2.48 (10.22%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Assembly Biosciences Employees
Assembly Biosciences had 73 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
73
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$973,932
Profits / Employee
-$87,438
Market Cap
529.91M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| REGENXBIO | 371 |
| Arvinas | 246 |
| ProKidney | 231 |
| Kyverna Therapeutics | 129 |
| Rezolute | 68 |
| Prothena Corporation | 67 |
| Altimmune | 57 |
| Contineum Therapeutics | 51 |
ASMB News
- 14 days ago - Assembly Biosciences price target raised to $45 from $40 at Mizuho - TheFly
- 21 days ago - Assembly Biosciences Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 24 days ago - Assembly Biosciences Transcript: AGM 2026 - Transcripts
- 25 days ago - Assembly Biosciences Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - Assembly Biosciences Announces Upcoming Investor Conference Presentations - GlobeNewsWire
- 4 weeks ago - Assembly Biosciences Announces the Closing of its Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 5 weeks ago - Assembly Biosciences announces expansion of ABI-6250 clinical development - TheFly
- 5 weeks ago - Assembly Biosciences Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire